See what happened at our first Phacilitate SIG: Automation event
The Automation SIG is focused on creating tangible outputs that extend beyond what you’ve learnt at the event. From the 2017 inaugural meeting we created two written pieces - the Rapporteur’s Report & the Automation Report.
Rapporteur’s Report 2017
At our inaragual Phacilitate Special Interest Group: Automation event, the focus was firmly on creating a roadmap towards 'Automation in Cell-Based Therapy Manufacturing and Supply Chain'.
Each of the working groups covered a specific theme or question and was tasked with arriving at a specific ‘Output’: conclusions, or better yet, action points for the sector as a whole to take forward and utilise in helping drive progress, whether that be in the realm of regulatory guideline development, standardisation, technology development, or defining strategic models for engagement for all stakeholders.
The Rapporteur’s Report includes what was discussed at each session and the conclusions reached. To download your free copy, please fill in the below form.
Report: The ROI of Automation in Cell-based therapy bioprocessing and supply chains
In this exclusive report produced in partnership with BioLacuna, we explore the role of automation in manufacturing risk management.
The report undertakes an analysis of current bioprocess solutions for cell-based therapies, including extracellular vesicles, and investigates both their utility and amenability to automation, It investigates different models for implementing automation, the benefits of bespoke vs off-the-shelf bioprocessing, and decision making around integrated vs outsorced manufacturing. The report carries out quantitative research on KOL attitudes towards various aspects of bioprocess automation, and conducted interviews with a number of industry leaders, generating insight into the current state of automation, and illuminating some of the challenges and opportunities within the field.
Please fill out the form below if you'd like to purchase the full report